The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2024
Filed:
Mar. 15, 2021
Applicant:
Novartis Ag, Basel, CH;
Inventors:
Vincent Bordas, Village-Neuf, FR;
Cara Brocklehurst, Leymen, FR;
Patrick Chene, Mulhouse, FR;
Pascal Furet, Thann, FR;
Vito Guagnano, Lecce, IT;
Patricia Imbach-Weese, Bielefeld, DE;
Joerg Kallen, Basel, CH;
Mickael Le Douget, Muespach, FR;
Edwige Liliane Jeanne Lorthiois, Niffer, FR;
Joseph McKenna, Nottingham, GB;
Bahaa Salem, Basel, CH;
Tobias Schmelzle, Riehen, CH;
Holger Sellner, Buchs, CH;
Nicolas Soldermann, Village-Neuf, FR;
Markus Voegtle, Lörrach, CH;
Markus Wartmann, Riehen, CH;
Assignee:
Novartis AG, Basel, CH;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4155 (2006.01); A61K 31/343 (2006.01); A61K 31/351 (2006.01); A61K 31/357 (2006.01); A61K 31/4025 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 31/41 (2006.01); A61K 31/426 (2006.01); A61K 31/443 (2006.01); A61K 31/4439 (2006.01); A61K 31/4525 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); C07D 307/81 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 405/10 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 407/04 (2006.01); C07D 407/12 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 491/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4155 (2013.01); A61K 31/343 (2013.01); A61K 31/351 (2013.01); A61K 31/357 (2013.01); A61K 31/4025 (2013.01); A61K 31/403 (2013.01); A61K 31/41 (2013.01); A61K 31/426 (2013.01); A61K 31/443 (2013.01); A61K 31/4439 (2013.01); A61K 31/4525 (2013.01); A61K 31/506 (2013.01); A61P 35/00 (2018.01); C07D 307/81 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 407/04 (2013.01); C07D 407/12 (2013.01); C07D 417/04 (2013.01);
Abstract
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof;